GB1479063A - Antibiotics - Google Patents

Antibiotics

Info

Publication number
GB1479063A
GB1479063A GB15748/75A GB1574875A GB1479063A GB 1479063 A GB1479063 A GB 1479063A GB 15748/75 A GB15748/75 A GB 15748/75A GB 1574875 A GB1574875 A GB 1574875A GB 1479063 A GB1479063 A GB 1479063A
Authority
GB
United Kingdom
Prior art keywords
ethanol
antibiotic
chloroform
absorption
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB15748/75A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1479063A publication Critical patent/GB1479063A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)

Abstract

1479063 Antibiotics PFIZER Inc 16 April 1975 [16 April 1974 17 Jan 1975] 15748/75 Heading C2A A synergistic antibiotic mixture comprises compounds 35, 763, 36, 926, 37, 277 and 37, 932 and miscellaneous lesser antibiotic components produced by cultivating Actinoplanes auranticolor ATCC 31011 under submerged aerobic conditions in an aqueous nutrient medium containing an assimilable source of carbon and nitrogen until substantial antibiotic activity is obtained and separating the antibiotic mixture therefrom. Antibiotic compound 37, 277 is in crystalline form and has an optical rotation of [α] D <SP>25‹</SP>= + 11‹ at a concentration of 1% in ethanol, absorption maxima in ethanol in the ultra-violet region at 225, 274, 282, 303 and 355 mÁ with E<SP>1%</SP> 1cm values of 309À3, 36.67, 45.01, 70 and 20, an average composition by weight of 60.91% C, 5.98% H, 10.45% N and 22.66% O, when dissolved in chloroform exhibits the absorption characteristics indicated in Fig. 1 (not shown), on heating decomposes between 145‹ and 150‹ C., is insoluble in diethyl ether, Lexane, treptane and water, slightly soluble in acetone and leuzene, and readily soluble in methanol ethanol, chloroform and methylene chloride. Antibiotic compound 36, 926 has an average composition by weight of 57.89% C, 6.78% H, 8.04% N and 27.29% O, a molecular formula C 26 H 35 N 3 0 7 , an optical rotation of [α] D <SP>25‹</SP>=-130‹ at a concentration of 1% in ethanol, absorption maximum in ethanol in the ultra-violet region of the spectrum at 214 mÁ. with E<SP>1%</SP> 1cm of 723À8, 8 when spectrum at 214 mÁ with E<SP>1%</SP> 1cm of 723À8, when pelleted on KBr exhibits the absorption characteristics indicated in Fig. 2 (not shown), and on heating, decomposition commences at 100‹ C., is soluble in ethanol, methanol, chloroform and methylene chloride and insoluble in diethyl ether, hexane and heptane. Antibiotic compound 35, 763 has the molecular formula C 26 H 27 N 3 O 7 , an optical rotation of [α] D <SP>25‹</SP>=-114‹ at a concentration of 1% in ethanol, absorption maximum in ethanol in the ultra violet region at 218 mÁ with E<SP>1%</SP> 1cm of 668.9, when pelleted in KBr exhibits the absorption characteristic indicated in Fig. 3 (not shown), is soluble in methanol, ethanol, chloroform and methylene chloride, insouble in diethyl ether, heptane and hexane, on heating decomposition commences at 100‹ C., has a M.Wt of 503 and an average composition by weight of 61À29% C, 6À73% H, 8À83% N and 23À15% O. Antibiotic compound 37, 932 is in crystalline form and has an optical rotation of [α] D <SP>25‹</SP> = + 5.0‹ at a concentration of 0.25% in chloroform, absorption maxima in ethanol in the ultra-violet region of the spectrum at 226, 276, 283, 305 and 355 mÁ with E<SP>1%</SP> 1cm values of 304.4, 36.8, 43.49, 70.25 and 20.07, an average composition by weight of 59.41% C, 6À01% H, 10À66% N and 23.92% O when pelleted in KBr exhibits the absorption characteristics indicated on Fig. 4 (not shown) and is soluble in methanol, ethanol, chloroform and methylene chloride, is insoluble in diethyl ether, hexane, heptane and water and on heating decomposition commences at 185‹ C. The antibiotic mixture or one or more of the antibiotics may be admixed with a pharmaceutically acceptable carrier to form a pharmaceutical composition. The antibiotic mixture or one or more of the antibiotics may be incorporated in an animal feed composition.
GB15748/75A 1974-04-16 1975-04-16 Antibiotics Expired GB1479063A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46129874A 1974-04-16 1974-04-16
US54180075A 1975-01-17 1975-01-17

Publications (1)

Publication Number Publication Date
GB1479063A true GB1479063A (en) 1977-07-06

Family

ID=27039975

Family Applications (1)

Application Number Title Priority Date Filing Date
GB15748/75A Expired GB1479063A (en) 1974-04-16 1975-04-16 Antibiotics

Country Status (26)

Country Link
JP (2) JPS548760B2 (en)
AR (1) AR207359A1 (en)
AU (1) AU475745B2 (en)
BG (1) BG28268A3 (en)
CA (1) CA1045568A (en)
CH (1) CH606423A5 (en)
CS (1) CS196262B2 (en)
DD (2) DD118119A5 (en)
DE (1) DE2516020A1 (en)
DK (1) DK138758B (en)
ES (1) ES436615A1 (en)
FI (1) FI54326C (en)
FR (1) FR2287915A1 (en)
GB (1) GB1479063A (en)
HU (1) HU171026B (en)
IE (1) IE40906B1 (en)
IL (1) IL47004A (en)
IT (1) IT1053258B (en)
LU (1) LU72292A1 (en)
NL (1) NL159436B (en)
NO (1) NO143107C (en)
PH (4) PH14603A (en)
RO (1) RO68835A (en)
SE (1) SE423246B (en)
SU (1) SU552907A3 (en)
YU (1) YU90275A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147714A (en) * 1984-08-14 1986-03-08 Agency Of Ind Science & Technol Graft polymerization process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE37892B1 (en) * 1972-07-31 1977-11-09 Lilly Co Eli Antibiotic a-2315 and process for preparation thereof

Also Published As

Publication number Publication date
DK161075A (en) 1975-10-17
DK138758B (en) 1978-10-23
NL159436B (en) 1979-02-15
FI54326C (en) 1978-11-10
CH606423A5 (en) 1978-11-30
NO751149L (en) 1975-10-17
PH13963A (en) 1980-11-12
DD118119A5 (en) 1976-02-12
CS196262B2 (en) 1980-03-31
FR2287915B1 (en) 1978-07-28
BG28268A3 (en) 1980-03-25
SE423246B (en) 1982-04-26
DE2516020A1 (en) 1975-11-20
NL7504453A (en) 1975-10-20
AU475745B2 (en) 1976-09-02
JPS5831919B2 (en) 1983-07-09
SE7503724L (en) 1975-10-17
PH13383A (en) 1980-03-25
FI751107A (en) 1975-10-17
IL47004A0 (en) 1975-06-25
IE40906L (en) 1975-10-16
IL47004A (en) 1977-10-31
LU72292A1 (en) 1976-03-17
AU7983375A (en) 1976-09-02
DD122778A5 (en) 1976-11-05
FI54326B (en) 1978-07-31
IE40906B1 (en) 1979-09-12
FR2287915A1 (en) 1976-05-14
JPS50145592A (en) 1975-11-21
CA1045568A (en) 1979-01-02
PH14603A (en) 1981-10-02
JPS51125752A (en) 1976-11-02
ES436615A1 (en) 1977-05-01
YU90275A (en) 1982-02-25
SU552907A3 (en) 1977-03-30
PH15618A (en) 1983-02-28
NO143107C (en) 1980-12-17
HU171026B (en) 1977-10-28
AR207359A1 (en) 1976-09-30
NO143107B (en) 1980-09-08
RO68835A (en) 1982-05-10
JPS548760B2 (en) 1979-04-18
DK138758C (en) 1979-04-17
IT1053258B (en) 1981-08-31

Similar Documents

Publication Publication Date Title
GB1498087A (en) Antibiotic azetidinopyrrole derivative
GB1436447A (en) Rapamycin and process of preparation
GB1491266A (en) Anti-tumor antibiotics aclacinomycins a and b
GB1458512A (en) Antibiotic substance
GB985598A (en) Improvements in or relating to antibiotics and their preparation
GB1454735A (en) Lincomycin production
GB1501144A (en) Cyclic ether antibiotics
ES445965A1 (en) Papulacandin derivatives and pharmaceutical compositions containing same
GB1479063A (en) Antibiotics
GB1314657A (en) Antibiotics
GB1500965A (en) Cyclic ether antibiotics
GB1525977A (en) Aminoglycoside antibiotic complex
KR840008817A (en) BBM-1675, a new anticancer antibiotic complex
GB1500847A (en) Antibiotic a process for its preparation and its use as a medicament
GB1494449A (en) Ionomycin
GB1225379A (en)
KR920009986A (en) Dainemycin C Antineoplastic Antibiotics
GB1457796A (en) Metabolite a-27106 and process for its preparation and use
GB1440288A (en) Antibiotic and process for producing the same
GB1504994A (en) Naphthyridinomycin antibiotics and preparation thereof
GB1500846A (en) Antibiotic a process for its preparation and its use as a medicament
GB1381180A (en) Antibiotic
ES460266A1 (en) Antibiotic bl580
GB1439668A (en) Antibiotic bm123 and production thereof
GB1388198A (en) Antibiotic fr-1923 and a process for the preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930416